155 related articles for article (PubMed ID: 36733112)
1. [A Case of Recurrent Breast Cancer with Multiple Bone Metastasis Effectively Treated by CDK4/6 Inhibitor in Addition to Aromatase Inhibitor].
Satoh E; Hara M; Uehira D; Yonekura K; Murakata A; Ohinata R; Toyofuku Y; Tanami H; Osanai T; Sugano N; Sakoma T
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1491-1493. PubMed ID: 36733112
[TBL] [Abstract][Full Text] [Related]
2. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
[TBL] [Abstract][Full Text] [Related]
3. Palbociclib with letrozole as second-line neo-systemic therapy after failure of neo-adjuvant chemotherapy for luminal type breast cancer: A case report.
Jung SU; Jung M; Choi JH; Jeon CW
Medicine (Baltimore); 2021 Apr; 100(14):e25175. PubMed ID: 33832078
[TBL] [Abstract][Full Text] [Related]
4. [Recurrent Breast Cancer with Bone Metastasis Effectively Treated with Abemaciclib plus Endocrine Therapy-A Case Report].
Adachi K; Nagae J; Kubota H; Suzuki S; Hirano T; Sakurai K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1845-1847. PubMed ID: 38303227
[TBL] [Abstract][Full Text] [Related]
5. The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.
Finn RS; Crown JP; Lang I; Boer K; Bondarenko IM; Kulyk SO; Ettl J; Patel R; Pinter T; Schmidt M; Shparyk Y; Thummala AR; Voytko NL; Fowst C; Huang X; Kim ST; Randolph S; Slamon DJ
Lancet Oncol; 2015 Jan; 16(1):25-35. PubMed ID: 25524798
[TBL] [Abstract][Full Text] [Related]
6. Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.
Porter K; Rosenzweig MQ
J Adv Pract Oncol; 2017 Mar; 8(2):164-168. PubMed ID: 29900024
[No Abstract] [Full Text] [Related]
7. CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis.
Gao JJ; Cheng J; Bloomquist E; Sanchez J; Wedam SB; Singh H; Amiri-Kordestani L; Ibrahim A; Sridhara R; Goldberg KB; Theoret MR; Kluetz PG; Blumenthal GM; Pazdur R; Beaver JA; Prowell TM
Lancet Oncol; 2020 Feb; 21(2):250-260. PubMed ID: 31859246
[TBL] [Abstract][Full Text] [Related]
8. Unusual recurrent metastasizing benign breast papilloma: a case report.
Jain AL; Mullins J; Smith JR; Valasareddy P; Miller E; Chaudhry A; Ryder J; Hare F; Ranganath H; Berry M; Robins D; Schwartzberg L; Vidal GA
J Med Case Rep; 2020 Feb; 14(1):33. PubMed ID: 32070435
[TBL] [Abstract][Full Text] [Related]
9. Progression-free Survival Outcome Is Independent of Objective Response in Patients With Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer Treated With Palbociclib Plus Letrozole Compared With Letrozole: Analysis From PALOMA-2.
Rugo HS; Finn RS; Gelmon K; Joy AA; Harbeck N; Castrellon A; Mukai H; Walshe JM; Mori A; Gauthier E; Lu DR; Bananis E; Martin M; Diéras V
Clin Breast Cancer; 2020 Apr; 20(2):e173-e180. PubMed ID: 31836434
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Ipsilateral Breast Cancer with Contralateral Axillary Node Recurrence after Right Breast Partial Mastectomy].
Adachi M; Hara M; Ishibashi N; Sasaki M; Tomii C; Ohshima N; Koshiishi H; Yoshimura T
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2198-2200. PubMed ID: 33468906
[TBL] [Abstract][Full Text] [Related]
11. [Successful Treatment of Estrogen Receptor Positive, HER2 Negative Breast Cancer with Life-Threatening Multiple Bone Metastases Using the Combination of Fulvestrant and Palbociclib-A Case Report].
Nakamura A; Shigekawa T; Asakawa H; Park K; Baba N
Gan To Kagaku Ryoho; 2021 Oct; 48(10):1251-1254. PubMed ID: 34657057
[TBL] [Abstract][Full Text] [Related]
12. [A Case of Bone Marrow Carcinomatosis Associated with Breast Cancer with Anemia and Thrombocytopenia Successfully Treated with Aromatase Inhibitor Therapy].
Takagi H; Fukai H; Misawa S; Kurogochi A; Kirii Y
Gan To Kagaku Ryoho; 2021 Oct; 48(10):1255-1257. PubMed ID: 34657058
[TBL] [Abstract][Full Text] [Related]
13. [Ethinylestradiol Following Everolimus plus Exemestane Was Effective in Postmenopausal Endocrine-Responsive Metastatic Breast Cancer - A Case Report].
Matsuoka A; Hirano A; Hattori A; Ogura K; Inoue H; Yukawa H; Sakaguchi S; Tanaka N; Kodera A; Kamimura M; Naritaka Y; Shimizu T
Gan To Kagaku Ryoho; 2016 Oct; 43(10):1219-1222. PubMed ID: 27760942
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant letrozole for postmenopausal estrogen receptor-positive, HER2-negative breast cancer patients, a study from the Danish Breast Cancer Cooperative Group (DBCG).
Skriver SK; Laenkholm AV; Rasmussen BB; Handler J; Grundtmann B; Tvedskov TF; Christiansen P; Knoop AS; Jensen MB; Ejlertsen B
Acta Oncol; 2018 Jan; 57(1):31-37. PubMed ID: 29168427
[TBL] [Abstract][Full Text] [Related]
15. Late distant recurrence of breast carcinoma and metastasis to the main bronchus and choroid: A case report.
Luo Z; Cai Q; Zhao Y; Wang X; Fu S; Zhai L
Medicine (Baltimore); 2018 May; 97(20):e10754. PubMed ID: 29768356
[TBL] [Abstract][Full Text] [Related]
16. [A Case of Postoperative Pulmonary Metastasis of Breast Cancer with Complete Response by Abemaciclib plus Fulvestrant Therapy].
Higashi T; Ozawa K; Takei S; Takagi S; Yokoyama M; Mase K; Moriya T; Takeshita A; Mizutani M
Gan To Kagaku Ryoho; 2022 May; 49(5):581-583. PubMed ID: 35578939
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy-Resistant Breast Cancer and Carcinomatous Pleuritis Successfully Treated with Abemaciclib plus Letrozole Therapy].
Nozaki Y; Yamamuro M; Tanaka N; Kamo N; Konishi J
Gan To Kagaku Ryoho; 2023 Apr; 50(4):477-479. PubMed ID: 37066461
[TBL] [Abstract][Full Text] [Related]
18. [Long-Term Effect of Fulvestrant for Locally Advanced Breast Cancer in an Elderly Patient - A Case Report].
Sakurai K; Fujisaki S; Kubota H; Hara Y; Suzuki S; Adachi K; Tomita R; Enomoto K; Hirano T
Gan To Kagaku Ryoho; 2018 Jan; 45(1):76-78. PubMed ID: 29362313
[TBL] [Abstract][Full Text] [Related]
19. [A case of non-palpating breast cancer with huge lymph node metastasis].
Hara Y; Sakurai K; Fujisaki S; Nagashima S; Suzuki S; Shibata M; Tomita R; Matsumoto K; Enomoto K; Amano S
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2014-6. PubMed ID: 22202269
[TBL] [Abstract][Full Text] [Related]
20. Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial.
Mamounas EP; Bandos H; Lembersky BC; Jeong JH; Geyer CE; Rastogi P; Fehrenbacher L; Graham ML; Chia SK; Brufsky AM; Walshe JM; Soori GS; Dakhil SR; Seay TE; Wade JL; McCarron EC; Paik S; Swain SM; Wickerham DL; Wolmark N
Lancet Oncol; 2019 Jan; 20(1):88-99. PubMed ID: 30509771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
